Since its inception in 2012, @MySCRS has conducted an annual survey to derive insights, reveal trends, and ensure the site perspective is represented. This article summarizes the 2021 survey's findings. #clinicalresearch #clinicalsites
Clinical Leader
14.4K posts
Clinical Leader
@ClinicalLeader1
This is the Twitter account for Clinical Leader. Follow us to stay on top of the latest thoughts, advancements, and news in clinical trials.
- Combining PROs And Clinical Data To Benefit Cancer Patients & Researchers bit.ly/2axjPcP
- Between 2000 and 2020, nearly 80% of #ClinicalTrial participants were white. The underrepresentation of diverse racial and ethnic groups is not new, but we must do more to address disparities. Here are five strategies for action. #patientdiversity
- Training the next generation of life sciences talent is a challenge that @MassBioEd is working to solve. It recently created two apprenticeship programs, one of which is for clinical trial associates. By @HalloranConsult
- @ClinicalLeader1 and @LifeSciLeader1 would like to recognize @Parexel for winning #CROLeadershipAwards in Capabilities, Compatibility, Expertise, Quality, and Reliability! For more information about the #CROLeadershipAwards, visit croleadershipawards.com/?utm_source=ed…
- Please empower your CRA's - good ones are worth their weight in gold - Greg Morosky #clf17
- The EMA now requires #PlainLanguageSummaries for #ClinicalTrials with sites in the EU. The FDA has no current regulations for PLS, but they fit into recent guidance documents. Optimize your PLS with these tips. By @HealthLitMedia #regulatorycompliance
- Shifting drug development based on patient insights - Katie Mazuk #CLF17
- Three Questions To Ask When Evaluating a Patient Recruitment Plan bit.ly/2dNOSBQ
- Brand new to this year's Clinical Leader Forum in #Philly are #graphicrecordings by @SeeYourWords illustrating each of the sessions. Stay tuned to see the boards for each topic of conversation! #CLF2018
- The Good Clinical Trials Collaborative was established to outline what “good” looks like for randomized #clinicaltrials. The guidance is not a manual, but is a compass that helps users explore why a particular approach will achieve the right outcome.
